Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2/3 SK-0503 for macular edema following branch retinal vein occlusion
jRCT2080221159Phase 3
- Sponsor
- Sanwa Kagaku Kenkyusho Co., Ltd.
- Start
- Jul 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of dexamethasone in macular edema and branch retinal vein occlusion (BRVO) (3 arms), sponsored by Sanwa Kagaku Kenkyusho Co., Ltd.
02
Drugs
dexamethasone
03
Conditions
macular edemabranch retinal vein occlusion (BRVO)
Beyond the preview
Go deeper on jRCT2080221159.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080221159.